The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Genetics of Myeloid Malignancies: Pathogenetic and Clinical Implications
Abstract
Myeloid malignancies are clonal disorders that are characterized by acquired somatic mutation in hematopoietic progenitors. Recent advances in our understanding of the genetic basis of myeloid malignancies have provided important insights into the pathogenesis of acute myeloid leukemia (AML) and myeloproliferative diseases (MPD) and have led to the development of novel therapeutic approaches. In this review, we describe our current state of understanding of the genetic basis of AML and MPD, with a specific focus on pathogenetic and therapeutic significance. Specific examples discussed include RAS mutations, KIT mutations, FLT3 mutations, and core binding factor rearrangements in AML, and JAK2 mutations in polycythemia vera, essential thrombocytosis, and chronic idiopathic myelofibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Le Couédic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,544
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., & Bloomfield, C. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.12.3835 · Cited by 3,267
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Self-citationGrimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Cheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
The World Health Organization (WHO) classification of the myeloid neoplasms
Vardiman, J. W., Harris, N. L., & Brunning, R. D. (2002) · Blood · doi:10.1182/blood-2002-04-1199 · Cited by 2,197
Creutzig, U., & Kaspers, G. J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.116 · Cited by 2,137
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R., Pasqualucci, L., La Starza, R., Diverio, D., Colombo, E., Santucci, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041974 · Cited by 1,892
Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schäkel, U., Platzbecker, U., Wermke, M., Bornhäuser, M., Ritter, M., Neubauer, A., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4326 · Cited by 1,735
Cools, J., DeAngelo, D. J., Gotlib, J., Stover, E. H., Legare, R. D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J. D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025217 · Cited by 1,718
Self-citationSlovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohamed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,601
Byrd, J. C. (2002) · Blood · doi:10.1182/blood-2002-03-0772 · Cited by 1,597
Kottaridis, P. D., Gale, R. E., Frew, M. E., Harrison, G., Langabeer, S. E., Belton, A. A., Walker, H., Wheatley, K., Bowen, D. T., Burnett, A. K., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1752 · Cited by 1,551
A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W.-M., Brard, G., Ngo, S. D., Davie, J. R., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,214
Golub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Self-citationActivating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Yamamoto, Y. (2001) · Blood · doi:10.1182/blood.v97.8.2434 · Cited by 1,150
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Self-citationAll-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
Tartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033
Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., Löffler, H., Sauerland, C. M., Serve, H., Büchner, T., et al. (2002) · Blood · doi:10.1182/blood.v100.1.59 · Cited by 973
Pabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901
Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
Fröhling, S., Schlenk, R. F., Breitruck, J., Benner, A., Kreitmeier, S., Tobis, K., Döhner, H., & Döhner, K. (2002) · Blood · doi:10.1182/blood-2002-05-1440 · Cited by 871
The role of FLT3 in haematopoietic malignancies
Stirewalt, D. L., & Radich, J. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1169 · Cited by 865
Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
Alland, L., Muhle, R., Hou, H., Potes, J., Chin, L., Schreiber-Agus, N., & DePinho, R. A. (1997) · Nature · doi:10.1038/387049a0 · Cited by 844
Borrow, J., Stanton, V. P., Andresen, J. M., Becher, R., Behm, F. G., Chaganti, R. S. K., Civin, C. I., Disteche, C., Dubé, I., Frischauf, A. M., et al. (1996) · Nature Genetics · doi:10.1038/ng0996-33 · Cited by 771
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., et al. (1999) · PubMed · doi:10.1182/blood.v93.9.3074 · Cited by 757
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732
Huntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697
Self-citationCytogenetics in acute leukemia
Mrózek, K., Heerema, N. A., & Bloomfield, C. D. (2004) · Blood Reviews · doi:10.1016/s0268-960x(03)00040-7 · Cited by 659
Stone, R. M., DeAngelo, D. J., Klimek, V., Galinsky, I., Estey, E., Nimer, S. D., Grandin, W., Lebwohl, D., Wang, Y., Cohen, P., et al. (2005) · Blood · doi:10.1182/blood-2004-03-0891 · Cited by 657
Self-citationPolycythemia Vera: Stem-Cell and Probable Clonal Origin of the Disease
Adamson, J. W., Fialkow, P. J., Murphy, S., Prchal, J. F., & Steinmann, L. (1976) · New England Journal of Medicine · doi:10.1056/nejm197610212951702 · Cited by 640
Whitman, S. P., Archer, K. J., Lin, F., Baldus, C. D., Becknell, B., Carlson, B. D., Carroll, A. J., Mrózek, K., Vardiman, J., George, S. L., et al. (2001) · PubMed · Cited by 633
Smith, B. D., Levis, M., Beran, M., Giles, F., Kantarjian, H., Berg, K., Murphy, K. M., Dauses, T., Allebach, J., & Small, D. (2004) · Blood · doi:10.1182/blood-2003-11-3775 · Cited by 632
Erickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631
Apperley, J. F., Gardembas, M., Melo, J. V., Russell-Jones, R., Bain, B. J., Baxter, E. J., Chase, A., Chessells, J. M., Colombat, M., Dearden, C. E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020150 · Cited by 630
Disruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612
Core-binding factors in haematopoiesis and leukaemia
Speck, N. A., & Gilliland, D. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc840 · Cited by 569
Self-citationWang, J., Hoshino, T., Redner, R. L., Kajigaya, S., & Liu, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10860 · Cited by 512
Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509
Preudhomme, C., Sagot, C., Boissel, N., Cayuela, J.-M., Tigaud, I., de Botton, S., Thomas, X., Raffoux, E., Lamandin, C., Castaigne, S., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0990 · Cited by 501
The Structural Basis for Autoinhibition of FLT3 by the Juxtamembrane Domain
Griffith, J., Black, J., Faerman, C., Swenson, L., Wynn, M., Lu, F., Lippke, J., & Saxena, K. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00505-7 · Cited by 499
Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N., & Ohki, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05933.x · Cited by 498
Peeters, P., Raynaud, S. D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Van Rompaey, L., Baens, M., Van den Berghe, H., et al. (1997) · Blood · doi:10.1182/blood.v90.7.2535 · Cited by 491
Kelly, L. M., Liu, Q., Kutok, J. L., Williams, I. R., Boulton, C. L., & Gilliland, D. G. (2002) · Blood · doi:10.1182/blood.v99.1.310 · Cited by 487
Self-citationLeukaemia stem cells and the evolution of cancer-stem-cell research
Huntly, B. J. P., & Gilliland, D. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1592 · Cited by 483
Self-citationAML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G. (2001) · Nature Medicine · doi:10.1038/86515 · Cited by 463
Fröhling, S., Schlenk, R. F., Stolze, I., Bihlmayr, J., Benner, A., Kreitmeier, S., Tobis, K., Döhner, H., & Döhner, K. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.060 · Cited by 458
Self-citationHiguchi, M., O'Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.-J., & Downing, J. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00016-8 · Cited by 440
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
Stirewalt, D. L., Kopecky, K. J., Meshinchi, S., Appelbaum, F. R., Slovak, M. L., Willman, C. L., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.11.3589 · Cited by 431
Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C. J., Burel, S. A., Lagasse, E., Weissman, I. L., Akashi, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171321298 · Cited by 431
Bone-Marrow Responses in Polycythemia Vera
(1974) · New England Journal of Medicine · doi:10.1056/nejm197406132902419 · Cited by 420
Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2004-05-1693 · Cited by 398
Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Identification of novel FLT‐3 Asp835 mutations in adult acute myeloid leukaemia
Abu‐Duhier, F. M., Goodeve, A. C., Wilson, G. A., Care, R. S., Peake, I. R., & Reilly, J. T. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02850.x · Cited by 388
Early signaling pathways activated by c-Kit in hematopoietic cells
Linnekin, D. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00078-3 · Cited by 385
Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.-J., van Deursen, J. M. A., Harada, H., & Downing, J. R. (1998) · Blood · doi:10.1182/blood.v91.9.3134 · Cited by 372
Schlenk, R. F., Benner, A., Krauter, J., Büchner, T., Sauerland, C., Ehninger, G., Schaich, M., Mohr, B., Niederwieser, D., Krahl, R., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.012 · Cited by 356
Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marín-Padilla, M., Tenen, D. G., Speck, N. A., & Zhang, D.-E. (1997) · Nature Genetics · doi:10.1038/ng0397-303 · Cited by 346
Mutation of CEBPA in Familial Acute Myeloid Leukemia
Smith, M. L., Cavenagh, J. D., Lister, T. A., & Fitzgibbon, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041331 · Cited by 328
Care, R. S., Valk, P. J. M., Goodeve, A. C., Abu‐Duhier, F. M., Geertsma‐Kleinekoort, W. M. C., Wilson, G. A., Gari, M. A., Peake, I. R., Löwenberg, B., & Reilly, J. T. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04362.x · Cited by 323
PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model
Kelly, L. M., Kutok, J. L., Williams, I. R., Boulton, C. L., Amaral, S. M., Curley, D. P., Ley, T. J., & Gilliland, D. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122233699 · Cited by 322
Self-citationDöhner, K., Tobis, K., Ulrich, R., Fröhling, S., Benner, A., Schlenk, R. F., & Döhner, H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.088 · Cited by 322
Self-citationTreatment of hypereosinophilic syndrome with imatinib mesilate
Gleich, G. J., Leiferman, K. M., Pardanani, A., Tefferi, A., & Butterfield, J. H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08505-7 · Cited by 306
Castilla, L. H., Garrett, L., Adya, N., Orlic, D., Dutra, A., Anderson, S., Owens, J., Eckhaus, M., Bodine, D., & Liu, P. P. (1999) · Nature Genetics · doi:10.1038/13776 · Cited by 302
Reuter, C. W. M., Morgan, M. A., & Bergmann, L. (2000) · Blood · doi:10.1182/blood.v96.5.1655 · Cited by 300
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera
Kralovics, R., Guan, Y., & Prchal, J. T. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00789-5 · Cited by 300
Mizuki, M., Schwäble, J., Steur, C., Choudhary, C., Agrawal, S., Sargin, B., Steffen, B., Matsumura, I., Kanakura, Y., Böhmer, F. D., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1677 · Cited by 298
Nuchprayoon, I., Meyers, S., Scott, L. M., Suzow, J., Hiebert, S., & Friedman, A. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5558 · Cited by 296
Gotlib, J., Cools, J., Malone, J. M., Schrier, S. L., Gilliland, D. G., & Coutré, S. E. (2004) · Blood · doi:10.1182/blood-2003-06-1824 · Cited by 290
Self-citationExpression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells
Ikeda, H., Kanakura, Y., Tamaki, T., Kuriu, A., Kitayama, H., Ishikawa, J., Kanayama, Y., Yonezawa, T., Tarui, S., & Griffin, J. (1991) · Blood · doi:10.1182/blood.v78.11.2962.2962 · Cited by 280
C/EBPα mutations in acute myeloid leukaemias
Nerlov, C. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1363 · Cited by 280
Mohi, M. G., Williams, I. R., Dearolf, C. R., Chan, G., Kutok, J. L., Cohen, S., Morgan, K., Boulton, C., Shigematsu, H., Keilhack, H., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.010 · Cited by 277
Self-citationChan, I. T., Kutok, J. L., Williams, I. R., Cohen, S., Kelly, L., Shigematsu, H., Johnson, L., Akashi, K., Tuveson, D. A., Jacks, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20476 · Cited by 270
Self-citationThe t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2
Reiter, A., Walz, C., Watmore, A., Schoch, C., Blau, I., Schlegelberger, B., Berger, U., Telford, N., Aruliah, S., Yin, J. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4263 · Cited by 269
Carroll, M., Tomasson, M. H., Barker, G. F., Golub, T. R., & Gilliland, D. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14845 · Cited by 268
Self-citationPreudhomme, C., Warot-Loze, D., Roumier, C., Grardel-Duflos, N., Garand, R., Lai, J. L., Dastugue, N., Macintyre, E., Denis, C., Bauters, F., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2862 · Cited by 263
Choudhary, C., Schwäble, J., Brandts, C., Tickenbrock, L., Sargin, B., Kindler, T., Fischer, T., Berdel, W. E., Müller-Tidow, C., & Serve, H. (2005) · Blood · doi:10.1182/blood-2004-07-2942 · Cited by 263
c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia
Gari, M., Goodeve, A., Wilson, G., Winship, P., Langabeer, S., Linch, D., Vandenberghe, E., Peake, I., & Reilly, J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01449.x · Cited by 262
A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia
Fiedler, W., Mesters, R., Tinnefeld, H., Loges, S., Staib, P., Dührsen, U., Flasshove, M., Ottmann, O. G., Jung, W., Cavalli, F., et al. (2003) · Blood · doi:10.1182/blood-2002-10-2998 · Cited by 262
Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia
Ozeki, K. (2004) · Blood · doi:10.1182/blood-2003-06-1845 · Cited by 262
Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.
Gilliland, D. G., Blanchard, K. L., Levy, J., Perrin, S., & Bunn, H. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6848 · Cited by 253
Self-citationGrowney, J. D., Clark, J. J., Adelsperger, J., Stone, R., Fabbro, D., Griffin, J. D., & Gilliland, D. G. (2005) · Blood · doi:10.1182/blood-2004-12-4617 · Cited by 249
Self-citationFrost, M. J., Ferrao, P. T., Hughes, T. P., & Ashman, L. K. (2002) · PubMed · Cited by 249
Baldus, C. D., Tanner, S. M., Ruppert, A. S., Whitman, S. P., Archer, K. J., Marcucci, G., Caligiuri, M. A., Carroll, A. J., Vardiman, J. W., Powell, B. L., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0359 · Cited by 241
Myelodysplastic and Myeloproliferative Disorders of Childhood: A Study of 167 Patients
Luna-Fineman, S., Shannon, K. M., Atwater, S. K., Davis, J., Masterson, M., Ortega, J., Sanders, J., Steinherz, P., Weinberg, V., & Lange, B. J. (1999) · Blood · doi:10.1182/blood.v93.2.459 · Cited by 235
Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
Bienz, M., Ludwig, M., Mueller, B. U., Oppliger Leibundgut, E., Ratschiller, D., Solenthaler, M., Fey, M. F., & Pabst, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1552 · Cited by 235
van Waalwijk van Doorn-Khosrovani, S. B., Erpelinck, C., Meijer, J., van Oosterhoud, S., van Putten, W. L. J., Valk, P. J. M., Berna Beverloo, H., Tenen, D. G., Löwenberg, B., & Delwel, R. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200216 · Cited by 235
Deguchi, K., Ayton, P. M., Carapeti, M., Kutok, J. L., Snyder, C. S., Williams, I. R., Cross, N. C. P., Glass, C. K., Cleary, M. L., & Gilliland, D. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00051-5 · Cited by 225
Self-citationConcepts of human leukemic development
Warner, J. K., Wang, J. C. Y., Hope, K. J., Jin, L., & Dick, J. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207933 · Cited by 225
Janssen, J. W., Steenvoorden, A. C., Lyons, J., Anger, B., Böhlke, J. U., Bos, J. L., Seliger, H., & Bartram, C. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9228 · Cited by 225
Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit
Akin, C., Brockow, K., D'Ambrosio, C., Kirshenbaum, A. S., Ma, Y., Longley, B. J., & Metcalfe, D. D. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00112-7 · Cited by 224
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.
Caligiuri, M. A., Strout, M. P., Lawrence, D. D., Arthur, D., Baer, M., Yu, F., Knuutila, S., Mrózek, K., Oberkircher, A. R., Marcucci, G., et al. (1998) · PubMed · Cited by 224
Schnittger, S., Weisser, M., Schoch, C., Hiddemann, W., Haferlach, T., & Kern, W. (2003) · Blood · doi:10.1182/blood-2003-03-0880 · Cited by 223
Cools, J., Stover, E. H., Boulton, C. L., Gotlib, J., Legare, R. D., Amaral, S. M., Curley, D. P., Duclos, N., Rowan, R., Kutok, J. L., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00108-9 · Cited by 216
Self-citationSide, L. E., Emanuel, P. D., Taylor, B., Franklin, J., Thompson, P., Castleberry, R. P., & Shannon, K. M. (1998) · Blood · doi:10.1182/blood.v92.1.267.413a31_267_272 · Cited by 207
FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells
Zheng, R., Levis, M., Piloto, O., Brown, P., Baldwin, B. R., Gorin, N. C., Beran, M., Zhu, Z., Ludwig, D., Hicklin, D., et al. (2004) · Blood · doi:10.1182/blood-2003-06-1969 · Cited by 205
STI571: A Paradigm of New Agents for Cancer Therapeutics
Mauro, M. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.325 · Cited by 202
Zhang, D.-E., Fujioka, K.-I., Hetherington, C. J., Shapiro, L. H., Chen, H.-M., Look, A. T., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8085-8095.1994 · Cited by 199
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia
Neubauer, A., Dodge, R., George, S., Davey, F., Silver, R., Schiffer, C., Mayer, R., Ball, E., Wurster-Hill, D., & Bloomfield, C. (1994) · Blood · doi:10.1182/blood.v83.6.1603.1603 · Cited by 199
Fragale, A., Tartaglia, M., Wu, J., & Gelb, B. D. (2004) · Human Mutation · doi:10.1002/humu.20005 · Cited by 194
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)
Flotho, C., Valcamonica, S., Mach-Pascual, S., Schmahl, G., Corral, L., Ritterbach, J., Hasle, H., Aricò, M., Biondi, A., & Niemeyer, C. (1999) · Leukemia · doi:10.1038/sj.leu.2401240 · Cited by 194
(1999) · PubMed · Cited by 194
Grundler, R., Miething, C., Thiede, C., Peschel, C., & Duyster, J. (2005) · Blood · doi:10.1182/blood-2004-11-4430 · Cited by 193
Zermati, Y., De Sepulveda, P., Féger, F., Létard, S., Kersual, J., Castéran, N., Gorochov, G., Dy, M., Ribadeau Dumas, A., Dorgham, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206120 · Cited by 191
CEBPA point mutations in hematological malignancies
Leroy, H., Roumier, C., Huyghe, P., Biggio, V, Fenaux, P., & Preudhomme, C. (2005) · Leukemia · doi:10.1038/sj.leu.2403614 · Cited by 190
Ross, T. S., Bernard, O. A., Berger, R., & Gilliland, D. G. (1998) · Blood · doi:10.1182/blood.v91.12.4419 · Cited by 186
Self-citationPrevalence of Priapism in Children and Adolescents With Sickle Cell Anemia
Mantadakis, E., Cavender, J. D., Rogers, Z. R., Ewalt, D. H., & Buchanan, G. R. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199911000-00013 · Cited by 183
Occurrence of myeloproliferative disorder in patients with Noonan syndrome
Bader-Meunier, B., Tchernia, G., Miélot, F., Fontaine, J. L., Thomas, C., Lyonnet, S., Lavergne, J. M., & Dommergues, J. P. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70273-7 · Cited by 177
Zheng, R., Friedman, A. D., Levis, M. J., Li, L., Weir, E. G., & Small, D. (2003) · Blood · doi:10.1182/blood-2003-06-1978 · Cited by 176
Schafer, W. R., Trueblood, C. E., Yang, C.-C., Mayer, M. P., Rosenberg, S., Poulter, C. D., Kim, S.-H., & Rine, J. (1990) · Science · doi:10.1126/science.2204115 · Cited by 176
Le, D. T., Kong, N., Zhu, Y., Lauchle, J. O., Aiyigari, A., Braun, B. S., Wang, E., Kogan, S. C., Le Beau, M. M., Parada, L., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2650 · Cited by 175
Kitabayashi, I., Ida, K., Morohoshi, F., Yokoyama, A., Mitsuhashi, N., Shimizu, K., Nomura, N., Hayashi, Y., & Ohki, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.846 · Cited by 172
Biology of chronic myelogenous leukemia—signaling pathways of initiation and transformation
Melo, J. V., & Deininger, M. W. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.03.008 · Cited by 166
Neurofibromatosis type 1 gene mutations in neuroblastoma
The, I., Murthy, A. E., Hannigan, G. E., Jacoby, L. B., Menon, A. G., Gusella, J. F., & Bernards, A. (1993) · Nature Genetics · doi:10.1038/ng0193-62 · Cited by 165
Durst, K. L., Lutterbach, B., Kummalue, T., Friedman, A. D., & Hiebert, S. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.607-619.2003 · Cited by 161
Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin.
Zanjani, E. D., Lutton, J. D., Hoffman, R., & Wasserman, L. R. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108706 · Cited by 161
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance
Radich, J., Kopecky, K., Willman, C., Weick, J., Head, D., Appelbaum, F., & Collins, S. (1990) · Blood · doi:10.1182/blood.v76.4.801.801 · Cited by 161
Caligiuri, M. A., Schichman, S. A., Strout, M. P., Mrózek, K., Baer, M. R., Frankel, S. R., Barcos, M. P., Herzig, G. P., Croce, C. M., & Bloomfield, C. D. (1994) · PubMed · Cited by 159
Steudel, C., Wermke, M., Schaich, M. A., Schäkel, U., Illmer, T., Ehninger, G., & Thiede, C. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10219 · Cited by 156
Mechanisms controlling pathogenesis and survival of leukemic stem cells
Jordan, C. T., & Guzmán, M. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207935 · Cited by 154
Takahashi, A., Satake, M., Yamaguchi‐Iwai, Y., Bae, S., Lu, J., Maruyama, M., Yw, Z., Oka, H., Arai, N., & Arai, K. (1995) · Blood · doi:10.1182/blood.v86.2.607.bloodjournal862607 · Cited by 152
Juvenile Myelomonocytic Leukemia and Noonan Syndrome
Choong, K. L. M., Freedman, M. H., Chitayat, D. A., Kelly, E., Taylor, G. P., & Zipursky, A. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199911000-00014 · Cited by 150
Grundler, R., Thiede, C., Miething, C., Steudel, C., Peschel, C., & Duyster, J. (2003) · Blood · doi:10.1182/blood-2002-11-3441 · Cited by 146
Internal tandem duplications of the FLT3 gene are present in leukemia stem cells
Levis, M. J., Murphy, K. M., Pham, R., Kim, K.-T., Stine, A., Li, L., McNiece, I., Smith, B. D., & Small, D. (2005) · Blood · doi:10.1182/blood-2004-05-1902 · Cited by 145
Klisovic, M. I., Maghraby, E. A., Parthun, M. R., Guimond, M., Sklenar, A. R., Whitman, S. P., Chan, K. K. L., Murphy, T., Anon, J., Archer, K. J., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402776 · Cited by 142
Efficacy and safety of imatinib in adult patients with c-kit–positive acute myeloid leukemia
Kindler, T., Breitenbuecher, F., Marx, A., Beck, J., Heß, G., Weinkauf, B., Duyster, J., Peschel, C., Kirkpatrick, C. J., Theobald, M., et al. (2004) · Blood · doi:10.1182/blood-2003-06-2071 · Cited by 142
Magnússon, M. K., Meade, K. E., Brown, K. E., Arthur, D. C., Krueger, L. A., Barrett, A. J., & Dunbar, C. E. (2001) · Blood · doi:10.1182/blood.v98.8.2518 · Cited by 141
Liang, J., Prouty, L. A., Williams, B. J., Dayton, M. A., & Blanchard, K. L. (1998) · Blood · doi:10.1182/blood.v92.6.2118 · Cited by 141
Morgan, M. A., Dolp, O., & Reuter, C. W. (2001) · Blood · doi:10.1182/blood.v97.6.1823 · Cited by 137
Adya, N., Stacy, T., Speck, N. A., & Liu, P. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7432 · Cited by 136
Grisolano, J. L., O’Neal, J., Cain, J., & Tomasson, M. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1531730100 · Cited by 135
Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia
Castilla, L. H., Perrat, P. N., Martinez, N. J., Landrette, S. F., Keys, R. A., Oikemus, S., Flanegan, J. B., Heilman, S. A., Garrett, L. J., Dutra, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400930101 · Cited by 133
Marcucci, G., Mrózek, K., & Bloomfield, C. D. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000149608.29685.d1 · Cited by 131
Schwaller, J., Anastasiadou, E., Cain, D., Kutok, J. L., Wojiski, S. A., Williams, I. R., Starza, R. L., Crescenzi, B., Sternberg, D., Andreasson, P., et al. (2001) · Blood · doi:10.1182/blood.v97.12.3910 · Cited by 130
Self-citationPrognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21)
Leroy, H., de Botton, S., Grardel, N., Darre, S., Leleu, X. P., Roumier, C., Morschhauser, F., Laï, J. L., Bauters, F., Fenaux, P., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403627 · Cited by 128
Krauter, J., Görlich, K., Ottmann, O. G., Lübbert, M., Döhner, H., Heit, W. F. W., Kanz, L., Ganser, A., & Heil, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.166 · Cited by 126
Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes
Lyons, J. F., Janssen, J. W. G., Bartram, C., Layton, M., & Mufti, G. J. (1988) · Blood · doi:10.1182/blood.v71.6.1707.1707 · Cited by 123
The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor
Lutterbach, B. A., Hou, Y., Durst, K. L., & Hiebert, S. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12822 · Cited by 122
Abe, A., Emi, N., Tanimoto, M., Terasaki, H., Marunouchi, T., & Saito, H. (1997) · Blood · doi:10.1182/blood.v90.11.4271 · Cited by 119
Schlenk, R. F., Benner, A., Hartmann, F., del Valle, F., Weber, C., Pralle, H., Fischer, J. T., Gunzer, U., Pezzutto, A., Weber, W. P., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403009 · Cited by 119
Self-citationWilkinson, K., Velloso, E. D. R. P., Lopes, L. F., Lee, C., Aster, J. C., Shipp, M. A., & Aguiar, R. C. T. (2003) · Blood · doi:10.1182/blood-2003-04-1150 · Cited by 116
Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction
Tickenbrock, L., Schwäble, J., Wiedehage, M., Steffen, B., Sargin, B., Choudhary, C., Brandts, C., Berdel, W. E., Müller‐Tidow, C., & Serve, H. L. (2005) · Blood · doi:10.1182/blood-2004-07-2924 · Cited by 112
Tomasson, M. H., Sternberg, D., Williams, I. R., Carroll, M. P., Cain, D., Aster, J. C., Ilaria, R. L., Etten, R. A. V., & Gilliland, D. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8902 · Cited by 111
Self-citationFröhling, S., Skelin, S., Liebisch, C., Scholl, C., Schlenk, R. F., Döhner, H., & Döhner, K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.155 · Cited by 109
Self-citationHirsch‐Ginsberg, C., LeMaistre, A., Kantarjian, H. M., Talpaz, M., Cork, A., Freireich, E., Trujillo, J., Lee, M., & Stass, S. A. (1990) · Blood · doi:10.1182/blood.v76.6.1214.1214 · Cited by 106
FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress
Libura, M. A., Asnafi, V., Tu, A., Delabesse, É., Tigaud, I., Cymbalista, F., Griscelli, A. B., Villarèse, P., Solbu, G., Hagemeijer, A., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0162 · Cited by 106
Kindler, T. (2004) · Blood · doi:10.1182/blood-2004-02-0660 · Cited by 102
Mutant N-ras Induces Myeloproliferative Disorders and Apoptosis in Bone Marrow Repopulated Mice
MacKenzie, K. L., Dolnikov, A., Millington, M., Shounan, Y., & Symonds, G. P. (1999) · Blood · doi:10.1182/blood.v93.6.2043.406k17_2043_2056 · Cited by 99
A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia
Spiekermann, K., Bagrintseva, K., Schoch, C., Haferlach, T., Hiddemann, W., & Schnittger, S. (2002) · Blood · doi:10.1182/blood-2002-03-0953 · Cited by 98
Kohl, T. M., Schnittger, S., Ellwart, J. W., Hiddemann, W., & Spiekermann, K. (2004) · Blood · doi:10.1182/blood-2004-06-2068 · Cited by 97
STAT3 activation is required for Asp816 mutant c-Kit induced tumorigenicity
Ning, Z.-Q., Li, J., McGuinness, M., & Arceci, R. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204590 · Cited by 94
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML
Jiang, J., Paez, J. G., Lee, J. C., Bo, R., Stone, R. M., DeAngelo, D. J., Galinsky, I. A., Wolpin, B. M., Jonasova, A. T., Herman, P. K., et al. (2004) · Blood · doi:10.1182/blood-2004-02-0712 · Cited by 90
Self-citationSTI571: A Paradigm of New Agents for Cancer Therapeutics
Mauro, M. J., O'Dwyer, M. E., Heinrich, M. C., & Druker, B. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.325 · Cited by 87
Kanno, Y., Kanno, T., Sakakura, C., Bae, S., & Ito, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4252 · Cited by 81
Transcriptional regulation of interleukin 3 gene expression in T lymphocytes.
Shoemaker, S. G., Hromas, R., & Kaushansky, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9650 · Cited by 80
Miles, D., Freedman, M. H., Stephens, K. G., Pallavicini, M. G., Sievers, E. L., Weaver, M., Grunberger, T., Thompson, P., & Shannon, K. (1996) · Blood · doi:10.1182/blood.v88.11.4314.bloodjournal88114314 · Cited by 79
MLL-rearranged leukemias: insights from gene expression profiling
Armstrong, S. A., Golub, T. R., & Korsmeyer, S. J. (2003) · Seminars in Hematology · doi:10.1016/s0037-1963(03)00196-3 · Cited by 79
Grand, F., Burgstaller, S., Kühr, T., Baxter, E. J., Webersinke, G., Thaler, J., Chase, A., & Cross, N. C. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2005 · Cited by 78
The FIP1L1-PDGFR?? kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia
Cools, J., Stover, E. H., Włodarska, I., Marynen, P., & Gilliland, D. G. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200401000-00008 · Cited by 75
Self-citationNovel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia
Stirewalt, D. L., Meshinchi, S., Kussick, S. J., Sheets, K. M., Pogosova‐Agadjanyan, E. L., Willman, C. L., & Radich, J. P. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04808.x · Cited by 63
Levine, R. L., Wadleigh, M., Sternberg, D., Wlodarska, I., Galinsky, I. A., Stone, R. M., DeAngelo, D. J., Gilliland, D. G., & Cools, J. (2004) · Leukemia · doi:10.1038/sj.leu.2403548 · Cited by 56
Self-citationSecond hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16).
Valk, P. J. M., Bowen, D., Frew, M. E., Goodeve, A. C., Löwenberg, B., & Reilly, J. T. (2004) · PubMed · Cited by 55
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
Sirulnik, A., Melnick, A., Zelent, A., & Licht, J. D. (2003) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(03)00062-8 · Cited by 54
Gozzini, A., Rovida, E., Sbarba, P. D., Galimberti, S., Santini, V., & Galimbert, S. (2003) · PubMed · Cited by 53
Wessels, J. W., Fibbe, W. E., van der Keur, D., Landegent, J. E., van der Plas, D. C., Ottolander, G. J. D., Roozendaal, K. J., & Beverstock, G. C. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90051-m · Cited by 50
Fröhling, S., Schlenk, R. F., Krauter, J., Thiede, C., Ehninger, G., Haase, D. T., Harder, L., Kreitmeier, S., Scholl, C., Caligiuri, M. A., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20152 · Cited by 41
Self-citationDown-modulation of the C/EBPα transcription factor in core binding factor acute myeloid leukemias
Cilloni, D., Carturan, S., Gottardi, E. M., Messa, F., Messa, E., Fava, M., Diverio, D., Guerrasio, A., Lo‐Coco, F., & Saglio, G. N. (2003) · Blood · doi:10.1182/blood-2003-07-2256 · Cited by 33
Farnesyltransferase inhibitor therapy in acute myelogenous leukemia.
Gotlib, J. R. (2005) · PubMed · Cited by 33
Smith, M. L., Arch, R., Smith, L., Bainton, N. J., Neat, M. J., Taylor, C., Bonnet, D. A., Cavenagh, J. D., Lister, T. A., & Fitzgibbon, J. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05324.x · Cited by 32
Lu, D., Nounou, R., Beran, M., Estey, E., Manshouri, T., Kantarjian, H., Keating, M. J., & Albitar, M. (2003) · Cancer · doi:10.1002/cncr.11037 · Cited by 23
Cited by
Estey, E., & Döhner, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69780-8 · Cited by 1,296
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Abdel-Wahab, O., Mullally, A., Hedvat, C., Garcia-Manero, G., Patel, J., Wadleigh, M., Malinge, S., Yao, J., Kilpivaara, O., Bhat, R., et al. (2009) · Blood · doi:10.1182/blood-2009-03-210039 · Cited by 727
Self-citationMolecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Marcucci, G., Haferlach, T., & Döhner, H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2554 · Cited by 570
Cornelissen, J. J., van Putten, W. L. J., Verdonck, L. F., Theobald, M., Jacky, E., Daenen, S. M. G., van Marwijk Kooy, M., Wijermans, P., Schouten, H., Huijgens, P. C., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025627 · Cited by 471
Dynamics of clonal evolution in myelodysplastic syndromes
Makishima, H., Yoshizato, T., Yoshida, K., Sekeres, M. A., Radivoyevitch, T., Suzuki, H., Przychodzen, B., Nagata, Y., Meggendorfer, M., Sanada, M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3742 · Cited by 422
Metadata
- Authors
- Fröhling, S., Scholl, C., Gilliland, D. G., & Levine, R. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-09-10
- Volume
- 23
- Issue
- 26
- Pages
- 6285-6295
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2140277442
- Cited by
- 353
- References
- 175
- FWCI
- 16.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.